ADAM17 and cancer: Malignant ascites-released membrane vesicles contain diverse activated proteases including MMP2, MMP9, uPA and ADAM17/TACE, together promoting ECM degradation and enhancing cancer cell invasiveness and metastasis (Carbotti et al., 2013; Graves et al., 2004).